planaformen.com
MEDPATH | Two Male Birth Control Options Advance Into Phase II Clinical Trials | Plan A™
Advancing Plan A™ alongside NLS-133, NEXT Life Sciences is responding directly to a long-unmet need, expanding contraceptive choice for men and couples worldwide.